Global Clinical Trials 2007-2018: Current Trends and Recent Advancements - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 22, 2019--The “Global Clinical Trials - Current Trends and Recent Advancement” report has been added to ResearchAndMarkets.com’s offering.
“Global Clinical Trials Current Trends and Recent Advancement”, provides an in-depth assessment of the current trends in the number of clinical trials globally, Top 10 therapy area, geography wise clinical trials, YOY clinical trials in top 10 therapy area.
An overview of clinical guidelines reforms has also been provided to show how regulatory affect the clinical trials cost and duration. How innovative clinical trials has solved those problems. This report also provides key insights on how CRO companies and Technological advancement has helped the pharma companies in cost and time.
Now clinical trials are conducted on global level and especially in those areas where cost of conducting clinical is less such as Pharma emerging markets. An overview of technological advancement has also been provided with collaboration of pharmaceutical companies.
ScopeHow many clinical trials being conducted worldwide? Which are top therapy areas in terms of number of clinical trials? Which type of sponsor vital in terms of conducting clinical trials in different therapeutic areas? Year over year clinical trials in Top 10 therapy areas. Which are the top 10 indication in top therapy areas? Top 10 indications in overall therapy areas. How many patients are being recruited in top 10 therapy areas? Average duration of clinical trials in top 10 therapy area. What is average recruitment size and clinical trials by Top 10 sponsor? What are the total number of deals completed between institutions and industries? How many clinical trials are ongoing in different geography areas? What are the main reasons which caused termination and withdrawal of clinical trials?
This report will allow you to:Understand the clinical trials analysis YOY (2007-2018) in Phase 0, Phase I, Phase II, Phase III, and Phase IV. Understand the analysis of top 10 therapy areas by number of clinical trials in 2007-2018 and in top therapy area top 10 indications. Gain an understanding of the major sponsor and major area of research and development. Understand the analysis of YOY FDA approval of precision medicine and primary end point analysis in oncology. Understand the clinical reforms in different countries and benefits of those changes. Understand the Novel approach of clinical trial design in oncology. Understand the role of clinical supply chain management to conduct clean in effective manner. Understand the role of technological advancement in clinical trials and importance of CRO for the same.
For more information about this report visit https://www.researchandmarkets.com/research/7w7v4k/global_clinical?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005391/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Clinical Trials
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/22/2019 04:17 AM/DISC: 01/22/2019 04:17 AM